Insider Trading Alert - BSX, VNDA, RLGY, SNDK And VRTX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 21, 2013, 155 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $250.02 to $153,391,332.00.

Highlighted Stocks Traded by Insiders:

Boston Scientific (BSX) - FREE Research Report

Pratt Timothy A. who is EVP, GC & Chief Admin Officer at Boston Scientific sold 20,132 shares at $11.94 on Nov. 21, 2013. Following this transaction, the EVP, GC & Chief Admin Officer owned 119,011 shares meaning that the stake was reduced by 14.47% with the 20,132 share transaction.

Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares sold: 150,436
  • 12-Week # shares sold: 150,436
  • 24-Week # shares sold: 247,809

The average volume for Boston Scientific has been 14.3 million shares per day over the past 30 days. Boston Scientific has a market cap of $16.0 billion and is part of the health care sector and health services industry. Shares are up 108.2% year to date as of the close of trading on Thursday.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 16 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Boston Scientific Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

These Stocks Are Ready to Reverse Course

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Cramer: These Sectors Look Bullish (Part III)